This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Krugluger, W. Articles by Cross, H. S. Search for Related Content PubMed PubMed Citation Articles by Krugluger, W. Articles by Cross, H. S.

Regulation of Genes of the Circadian Clock in Human Colon Cancer: Reduced Period-1 and Dihydropyrimidine Dehydrogenase Transcription Correlates in High-Grade Tumors

Departments of ¹ Clinical Chemistry, ² Internal Medicine I, ³ Surgery, and ⁴ Pathology, Hospital Rudolfstiftung, and ⁵ Institute of Pathophysiology, Medical University of Vienna, Vienna, Austria

Requests for reprints: Walter Krugluger, Department of Clinical Chemistry, Rudolfstiftung Hospital Juchgasse 23, A-1030 Vienna, Austria. Phone: 43-1-71165-3317; Fax: 43-1-71165-3309; E-mail: walter.krugluger{at}wienkav.at.

Expression of dihydropyrimidine dehydrogenase (DPD) displays a regular daily oscillation in nonmalignant cells. In colorectal cancer cells, the expression of this 5-fluorouracil–metabolizing enzyme is decreased, but the reason remains unclear. In this study, we analyzed by real-time reverse transcription-PCR (RT-PCR) the expression of DPD and of members of the cellular oscillation machinery, period 1 (Per1), period 2 (Per2), and CLOCK, in primary colorectal tumors and normal colon mucosa derived from the same patients. Analysis of tumors according to differentiation grade revealed a 0.46-fold (P = 0.005) decrease for DPD mRNA and a 0.49-fold (P = 0.004) decrease for Per1 mRNA in undifferentiated (G3) tumors compared with paired normal mucosa. In this tumor cohort, the correlation between DPD and Per1 levels was r = 0.64, P < 0.01. In moderately differentiated (G2) colon carcinomas, reduction of DPD and Per1 mRNA levels did not reach significance, but a significant correlation between the respective mRNA levels was detectable (r = 0.54; P < 0.05). The decrease and correlation of DPD and Per1 mRNA levels were even more pronounced in female (G3) patients (DPD: female, 0.35-fold, P < 0.001 versus male, 0.58-fold, P < 0.05; and Per1: female, 0.47-fold, P < 0.01 versus male, 0.52-fold, P < 0.01). The highly significant correlation of DPD mRNA with Per1 mRNA expression suggests control of DPD transcription by the endogenous cellular clock, which is more pronounced in women. Our results also revealed a disturbed transcription of Per1 during tumor progression, which might be the cause for disrupted daily oscillation of DPD in undifferentiated colon carcinoma cells. [Cancer Res 2007;67(16):7917–22]

This article has been cited by other articles:

				P. A. Wood, X. Yang, A. Taber, E.-Y. Oh, C. Ansell, S. E. Ayers, Z. Al-Assaad, K. Carnevale, F. G. Berger, M. M. O. Pena, et al. Period 2 Mutation Accelerates ApcMin/+ Tumorigenesis Mol. Cancer Res., November 1, 2008; 6(11): 1786 - 1793. [Abstract] [Full Text] [PDF]

				F. Levi, E. Filipski, I. Iurisci, X. M. Li, and P. Innominato Cross-talks between Circadian Timing System and Cell Division Cycle Determine Cancer Biology and Therapeutics Cold Spring Harb Symp Quant Biol, January 1, 2007; 72(0): 465 - 475. [Abstract] [PDF]

				R. V. Kondratov and M. P. Antoch The Clock Proteins, Aging, and Tumorigenesis Cold Spring Harb Symp Quant Biol, January 1, 2007; 72(0): 477 - 482. [Abstract] [PDF]